In the above-named article by Smit MA, van Kinschot CMJ, van der Linden J, van Noord C, and Kos S (Endocrine Reviews. 2019;40(6):1468–1480; doi: 10.1210/er.2018-00220), the following error occurred in the published paper: An error was made in the drafting of figure 1. The inhibitory line from 1,25-dihydroxyvitamin D to FGF23 should have been an arrow, indicating stimulation, not inhibition.

中文翻译：

---

勘误表：“临床指南和PTH测量：试验产生重要吗？”

在Smit MA的上述文章中，van Kinschot CMJ，van der Linden J，van Noord C和Kos S（Endocrine Reviews。2019; 40（6）：1468-1480; doi：10.1210 / er.2018-00220 ），已发表的论文发生了以下错误：图1的草稿中出现了错误。从1,25-二羟基维生素D到FGF23的抑制线应该是箭头，表示刺激，而不是抑制。